Home Tools
Log in
Cart

Search Result

Search Results for " ravtansine "

8

Compounds

Cat No. Product Name Synonyms Targets
T15141 DM4 Ravtansine Others , Microtubule Associated
DM4 (Ravtansine) can be used in the preparation of antibody drug conjugate and it is an antitubulin agent. It can inhibit cell division.
T77907 Tusamitamab ravtansine HuMAb2-3-SPDB-DM4,SAR-408701
Tusamitamab ravtansine (SAR-408701) is a DM4-linked anti-CEACAM5 antibody-drug conjugate (ADC) comprising a humanized monoclonal antibody targeting carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) conj...
T76940 Cantuzumab ravtansine
Cantuzumab ravtansine (IMGN242; huC242-DM4), an antibody-drug conjugate (ADC), consists of the humanized monoclonal antibody huC242 covalently bonded through a disulfide linkage to the cytotoxic agent DM4 (DM4). This com...
T77825 Mirvetuximab soravtansine IMGN853
Mirvetuximab soravtansine (IMGN853), an antibody-drug conjugate (ADC), integrates the cytotoxic agent DM4 with the humanized monoclonal antibody M9346A through a covalent bond. This compound targets folate receptor 1 (FO...
T77122 Praluzatamab Others
Praluzatamab is a monoclonal antibody targeting an activated white blood cell adhesion molecule (ALCAM/CD116). Praluzatamab is a naked antibody to Praluzatamab ravtansine and can be used to synthesize antibody active mol...
T77748 Tusamitamab Others
Tusamitamab is an IgG1 monoclonal antibody targeting CEACAM5 and is the naked antibody to Tusamitamab ravtansine.Tusamitamab can be used to synthesize the antibody-activator coupling Tusamitamab ravtansine.
T76857 Anetumab Others
Anetumab is a novel fully human anti-mesothelin IgG1 antibody that is a naked antibody to Anetumab ravtansine.Anetumab can be used to synthesize the antibody-activated molecule coupling, Anetumab ravtansine.Anetumab can ...
T77911 Cantuzumab
Cantuzumab, a monoclonal antibody, binds to the CanAg antigen and is commonly conjugated with various cytotoxic agents to form antibody-drug conjugates (ADCs), including Cantuzumab mertansine and Cantuzumab ravtansine [1...
TargetMol